General Biologicals Corporation (TPEX:4117)
7.60
-0.85 (-10.06%)
Oct 20, 2026, 1:40 PM CST
| Market Cap | 541.56M -40.6% |
| Revenue (ttm) | 260.23M +3.5% |
| Net Income | 518.98M |
| EPS | 7.64 |
| Shares Out | 70.79M |
| PE Ratio | 1.00 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 362,881 |
| Open | 8.08 |
| Previous Close | 8.45 |
| Day's Range | 6.23 - 8.08 |
| 52-Week Range | 3.50 - 17.30 |
| Beta | 0.58 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |